We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

ROCHE DIAGNOSTICS CORP

Roche Diagnostics Corporation is the North American headquarters of Roche Diagnostics, a global leader in diagnostics... read more Featured Products: More products

Download Mobile App




Advanced Glucose Monitor Enables Consistent Diabetes Management

By Simone Ciolek
Posted on 06 Sep 2016
A next-generation glucometer uses a mobile app and cloud-based support for reliable diabetes data management and remote monitoring.

The Accu-Chek Guide blood glucose monitoring system includes a lancet, the glucometer, and test strips with a large, easy-edge dosing area. More...
The strips are provided in a spill-resistant SmartPack vial, which helps users remove just one strip at a time, thus avoiding wastage or contamination. Blood glucose reading are analyzed on the device itself, with on-board pattern detection algorithms used to identify crests and troughs on the data chart and increase user awareness to the causes of blood glucose level fluctuations.

A Bluetooth smartphone app communicates with the glucometer and stores all the readings on the cloud via the Accu-Chek Connect diabetes management solution, which guarantees secure online data exchange and automatic logging. People with diabetes, caregivers, and healthcare providers can then share diabetes information virtually anywhere. The Accu-Chek Guide blood glucose monitoring system is a product of Roche Diagnostics (Basel, Switzerland). Initial launch will be in Denmark, Switzerland, and Australia.

“As the global leader in diabetes management we are dedicated to supporting people with diabetes, in thinking less about their daily therapy routines,” said Roland Diggelmann, CEO of Roche Diagnostics. “We are very excited to introduce this innovative system that simplifies blood glucose monitoring and improves the testing experience.”

Related Links:
Roche Diagnostics



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Emergency Ventilator
Shangrila935
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.